Skip to main content

Two Epstein-Barr Virus Glycoprotein Complexes

  • Chapter
Epstein-Barr Virus and Human Cancer

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 258))

Abstract

The envelopes of all herpesviruses contain multiple glycoprotein species, each one of which is potentially important to virus entry, to virus egress and to trafficking of virus-producing cells throughout the body. In addition, membrane-associated proteins or glycoproteins that are found in the infected cell, but not in the virion, may influence virus assembly and yield. Thus, as a class these molecules have a major impact on virus tropism and virus load and contribute significantly to the outcome of infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anagnastopoulos IMH, Kreschel C, Stein H (1995) Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744–750

    Google Scholar 

  • Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–211

    Article  PubMed  CAS  Google Scholar 

  • Barnett BC, Dolan A, Telford EAR, Davison AJ, McGeoch DJ (1992) A novel herpes simplex virus gene (UL49A) encodes a putative membrane protein with counterparts in other herpesviruses. J Gen Virol 73:2167–2171

    Article  PubMed  CAS  Google Scholar 

  • Beisel C, Tanner J, Matsuo T, Thorley-Lawson D, Kezdy F, Kieff E (1985) Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene. J Virol 54:665–674

    PubMed  CAS  Google Scholar 

  • Borza C, Hutt-Fletcher LM (1998) Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of the epithelial line SVKCR2. J Virol 72:7577–7582

    PubMed  CAS  Google Scholar 

  • Brack AR, Dijkstra JM, Granzow H, Klupp BG, Mettenleiter TC (1999) Inhibition of virion maturation by simultaneous deletion of glycoproteins E, I, and M of Pseudorabies virus. J Virol 73: 5364–5372

    PubMed  CAS  Google Scholar 

  • Emini EA, Luka J, Armstrong ME, Keller PM, Ellis RW, Pearson GR (1987) Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster glycoprotein II and the herpes simplex virus glycoprotein B. Virology 157:552–555

    Article  PubMed  CAS  Google Scholar 

  • Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d complement CR2. Proc Natl Acad Sci USA 81:4510–4516

    Article  PubMed  CAS  Google Scholar 

  • Gayle MA, Sims JE, Dower SK, Slack JL (1994) Monoclonal antibody 1994–2001 (also known as ALVA 42) reported to recognize type II IL-1 receptor is specific for HLA-DR alpha and beta chains. Cytokine 6:83–86

    Article  PubMed  CAS  Google Scholar 

  • Gong M, Kieff E (1990) Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/ 220 and gp110. J Virol 64:1507–1516

    PubMed  CAS  Google Scholar 

  • Gong M, Ooka T, Matsuo T, Kieff E (1987) Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB. J Virol 61:499–508

    PubMed  CAS  Google Scholar 

  • Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, Freese UK (1985) Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. New Engl J Med 313:1564–1571

    Article  PubMed  CAS  Google Scholar 

  • Gulley ML, Pulitzer DR, Eagan PA, Schneider BG (1996) Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol 27:20–27

    Article  PubMed  CAS  Google Scholar 

  • Haddad RS, Hutt-Fletcher LM (1989) Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J Virol 63:4998–5005

    PubMed  CAS  Google Scholar 

  • Heineman T, Gong M, Sample J, Kieff E (1988) Identification of the Epstein-Barr virus gp85 gene. J Virol 62:1101–1107

    PubMed  CAS  Google Scholar 

  • Herrold RE, Marchini A, Frueling S, Longnecker R (1995) Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo. J Virol 70:2049–2054

    Google Scholar 

  • Jöns A, Granzlow H, Kuchling R, Mettenleiter TC (1996) The UL49.5 gene of Pseudorabies virus codes for an O-glycosylated structural protein of the virus envelope. J Virol 70:1237–1241

    PubMed  Google Scholar 

  • Knox PG, Young LS (1995) Epstein-Barr virus infection of CR2-transfected epithelial cells reveals the presence of MHC class II on the virion. Virology 213:147–157

    Article  PubMed  CAS  Google Scholar 

  • Kurilla MG, Heineman T, Davenport LC, Kieff E, Hutt-Fletcher LM (1995) A novel Epstein-Barr virus glycoprotein gp150 expressed from the BDLF3 open reading frame. Virology 209:108–121

    Article  PubMed  CAS  Google Scholar 

  • Lake CM, Molesworth SJ, Hutt-Fletcher LM (1998) The Epstein-Barr virus (EBV) gN homolog BLRF1 encodes a 15kDa glycoprotein that cannot be authentically processed unless it is co-expressed with the EBV gM homolog BBRF3. J Virol 72:5559–5564

    PubMed  CAS  Google Scholar 

  • Lee SK (1999) Four consecutive arginine residues at positions 836–839 of EBV gp110 determine intracellular localization of gp110. Virology 264:350–358

    Article  PubMed  CAS  Google Scholar 

  • Lee SK, Longnecker R (1997) The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication. J Virol 71:4092–4097

    PubMed  CAS  Google Scholar 

  • Lemon SM, Hutt LM, Shaw JE, Li J-LH, Pagano JS (1977) Replication of EBV in epithelial cells during infectious mononucleosis. Nature 268:268–270

    Article  PubMed  CAS  Google Scholar 

  • Li QX, Spriggs MK, Kovats S, Turk SM, Comeau MR, Nepom B, Hutt-Fletcher LM (1997) Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 71:4657–4662

    PubMed  CAS  Google Scholar 

  • Li QX, Turk SM, Hutt-Fletcher LM (1995) The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol 69:3987–3994

    PubMed  CAS  Google Scholar 

  • Li QX, Young LS, Niedobitek G, Dawson CW, Birkenbach M, Wang F, Rickinson AB (1992) Epstein-Barr virus infection and replication in a human epithelial system. Nature 356:347–350

    Article  PubMed  CAS  Google Scholar 

  • Mackett M, Conway MJ, Arrand JR, Haddad RS, Hutt-Fletcher LM (1990) Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI 1 fragment. J Virol 64:2545–2552

    PubMed  CAS  Google Scholar 

  • Mellman I, Pierre P, Amigorena S (1995) Lonely MHC molecules seeking immunogenic peptides for meaningful relationships. Current Opinion in Cell Biology 7:564–572

    Article  PubMed  CAS  Google Scholar 

  • Miller N, Hutt-Fletcher LM (1988) A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus. Journal of Virology 62:2366–2372

    PubMed  CAS  Google Scholar 

  • Modrow S, Hoflacker B, Wolf H (1992) Identification of a protein encoded in the EB-viral open reading frame BMRF2. Arch Virol 127:379–386

    Article  PubMed  CAS  Google Scholar 

  • Nemerow GR, Houghton RA, Moore MD, Cooper NR (1989) Identification of the epitope in the major envelope proteins of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell 56:369–377

    Article  PubMed  CAS  Google Scholar 

  • Nemerow GR, Wolfert R, McNaughton M, Cooper NR (1985) Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 55:347–351

    PubMed  CAS  Google Scholar 

  • Niedobitek G, Herbst H, Young LS, Brooks L, Masucci MG, Crooker J, Rickinson A, Stein H (1992) Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood 79: 2520–2526

    PubMed  CAS  Google Scholar 

  • Nolan LA, Morgan AJ (1995) The Epstein-Barr virus open reading frame BDLF3 codes for a 100–150kDa glycoprotein. J Gen Virol 76:1381–1392

    Article  PubMed  CAS  Google Scholar 

  • Oba DE, Hutt-Fletcher LM (1988) Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame. J Virol 62:1108–1114

    PubMed  CAS  Google Scholar 

  • Osato T, Imai S (1996) Epstein-Barr virus and gastric carcinoma. Semin Cancer Biol 7:175–182

    Article  PubMed  CAS  Google Scholar 

  • Papworth MA, Van Dijk AA, Benyon GR, Allen TD, Arrand JR, Mackett M (1997) The processing, transport and heterologous expression of Epstein-Barr virus gp110. J Gen Virol 78:2179–2189

    PubMed  CAS  Google Scholar 

  • Penaranda ME, Lagenaur LA, Pierek LT, Berline JW, MacPhail LA, Greenspan D, Greenspan J, Palefsky JM (1997) Expression of Epstein-Barr virus BMRF-2 and BDLF-3 genes in hairy leuko-plakia. J Gen Virol 78:3361–3370

    PubMed  CAS  Google Scholar 

  • Sinclair AJ, Farrell PJ (1995) Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus. J Virol 69:5461–5468

    PubMed  CAS  Google Scholar 

  • Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. New Engl J Med 310:1225–1230

    Article  PubMed  CAS  Google Scholar 

  • Spear PG (1993) Entry of alphaviruses into cells. Semin Virol 4:167–180

    Article  CAS  Google Scholar 

  • Spriggs MK, Armitage RJ, Comeau MR, Strockbine L, Farrah T, MacDuff B, Ulrich D, Alderson MR, Mullberg J, Cohen JI (1996) The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J Virol 70:5557–5563

    PubMed  CAS  Google Scholar 

  • Strnad BC, Schuster T, Klein R, Hopkins RFI, Witmer T, Neubauer R, Rabin H (1982) Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen. J Virol 41:258–264

    PubMed  CAS  Google Scholar 

  • Sugano N, Chen W, Roberts ML, Cooper NR (1997) Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF B induction. J Exp Med 186:731–737

    Article  PubMed  CAS  Google Scholar 

  • Tanner J, Weis J, Fearon D, Whang Y, Kieff E (1987) Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50:203–213

    Article  PubMed  CAS  Google Scholar 

  • Tanner J, Whang Y, Sample J, Sears A, Keiff E (1988) Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J Virol 62:4452–4464

    PubMed  CAS  Google Scholar 

  • Thorley-Lawson DA, Miyashita EM, Khan G (1996) Epstein-Barr virus and the B cell: that’s all it takes. Trends Microbiol 4:204–208

    Article  PubMed  CAS  Google Scholar 

  • Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway C, Cheng-meyer C, Robinson J, Maddon PJ, Moore JP (1996) CD-4 dependent antibody sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184–187

    Article  PubMed  CAS  Google Scholar 

  • Wang X, Hutt-Fletcher LM (1998) Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J Virol 72:158–163

    PubMed  CAS  Google Scholar 

  • Wang X, Kenyon WJ, Li QX, Mullberg J, Hutt-Fletcher LM (1998) Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J Virol 72:5552– 5558

    PubMed  CAS  Google Scholar 

  • Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, Gerard C, Sodroski J (1996) CD-4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179–183

    Article  PubMed  CAS  Google Scholar 

  • Yaswen LR, Stephens EB, Davenport LC, Hutt-Fletcher LM (1993) Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 195:387–396

    Article  PubMed  CAS  Google Scholar 

  • Yoshiyama H, Imai S, Shimizu N, Takada K (1997) Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 71:5688–5691

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hutt-Fletcher, L.M., Lake, C.M. (2001). Two Epstein-Barr Virus Glycoprotein Complexes. In: Takada, K. (eds) Epstein-Barr Virus and Human Cancer. Current Topics in Microbiology and Immunology, vol 258. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56515-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56515-1_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62568-8

  • Online ISBN: 978-3-642-56515-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics